Skip to main content
Premium Trial:

Request an Annual Quote

... and Bruker Posts 90-Percent Jump in Q1 Profit Despite Slight Revenue Slip

NEW YORK, May 3 (GenomeWeb News) - Bruker BioSciences today posted a slight drop in first quarter revenues even though net income swelled by nearly 90 percent.

 

For the quarter ended March 31, revenues were $74.4 million, down less than 1 percent from the $74.9 the company earned in the first quarter of 2005.

 

Bruker said that it spent $10.3 million on R&D in the first quarter, compared to $11 million in the comparable period last year.

 

Profit in the quarter rose roughly 90 percent to $776,000, from $417,000 in the year-ago period.

 

As of March 31, Bruker had $96 million in cash and cash equivalents.

The Scan

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.

Effectiveness May Decline, Data From Israel Suggests

The New York Times reports that new Israeli data suggests a decline in Pfizer-BioNTech SARS-CoV-2 vaccine effectiveness against Delta variant infection, though protection against severe disease remains high.

To See Future Risk

Slate looks into the use of polygenic risk scores in embryo screening.

PLOS Papers on Methicillin-Resistant Staphylococcus, Bone Marrow Smear Sequencing, More

In PLOS this week: genomic analysis of methicillin-resistant Staphylococcus pseudintermedius, archived bone marrow sequencing, and more.